Now Available: Final Rule for FDAAA 801 and NIH Policy on Clinical Trial Reporting
1 study found for:    23334994 [PUBMED-IDS]
Show Display Options
Rank Status Study
1 Completed Anti-CD20 Antibody Therapy for Sjogren's Syndrome
Condition: Sjogren's Syndrome
Intervention: Drug: Rituximab

Study has passed its completion date and status has not been verified in more than two years.